Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(1.06)
# 2058
Out of 5,340 analysts
103
Total ratings
43.10%
Success rate
2.17%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VNDA Vanda Pharmaceutical... | Assumes: Overweight | 13 | 4.17 | 211.75% | 1 | May 14, 2025 | |
BMRN Biomarin Pharmaceuti... | Reiterates: Overweight | 90 90 | 59.49 | 51.29% | 15 | Feb 20, 2025 | |
VRTX Vertex Pharmaceutica... | Reiterates: Overweight | 480 480 | 438.51 | 9.46% | 22 | Feb 11, 2025 | |
BMY Bristol-Myers Squibb | Maintains: Neutral | 50 55 | 46.77 | 17.6% | 9 | Feb 4, 2025 | |
GILD Gilead Sciences | Reiterates: Neutral | 80 80 | 102.47 | -21.93% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 594.5 | 70.73% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 272.42 | 48.67% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 285.13 | -22.84% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 8.2 | 21.95% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 4.38 | 48.4% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 38.79 | 85.61% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | n/a | n/a | 2 | Feb 23, 2023 |